Editorials
SGLT2 inhibitors and kidney outcomes in the real world
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1584 (Published 29 April 2020) Cite this as: BMJ 2020;369:m1584Linked Research
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events
Linked Analysis
Communicating emerging risks of SGLT2 inhibitors